Saikosaponins Targeting Programmed Cell Death as Anticancer Agents: Mechanisms and Future Perspectives

Xiao Xiao, Chunfang Gao Department of Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People's Republic of ChinaCorrespondence: Chunfang Gao, Department of Clinic...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao X (Author), Gao C (Author)
Format: Book
Published: Dove Medical Press, 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2dbf8aeb00e341a082b2713a0b53b5eb
042 |a dc 
100 1 0 |a Xiao X  |e author 
700 1 0 |a Gao C  |e author 
245 0 0 |a Saikosaponins Targeting Programmed Cell Death as Anticancer Agents: Mechanisms and Future Perspectives 
260 |b Dove Medical Press,   |c 2024-08-01T00:00:00Z. 
500 |a 1177-8881 
520 |a Xiao Xiao, Chunfang Gao Department of Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People's Republic of ChinaCorrespondence: Chunfang Gao, Department of Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People's Republic of China, Tel +86-21-65161782-1210, Email gaocf1115@163.com; gaocf1115@shutcm.edu.cnAbstract: Saikosaponins (SS), which are major bioactive compounds in Radix Bupleuri, have long been used clinically for multicomponent, multitarget, and multipathway therapeutic strategies. Programmed cell death (PCD) induction is among the multiple mechanisms of SS and mediates the anticancer efficacy of this drug family. Although SS show promise for anticancer therapy, the available data to explain how SS mediate their key anticancer effects through PCD (apoptosis, autophagy, ferroptosis, and pyroptosis) remain limited and piecemeal. This review offers an extensive analysis of the key pathways and mechanisms involved in PCD and explores the importance of SS in cancer. We believe that high-quality clinical trials and a deeper understanding of the pharmacological targets involved in the signalling cascades that govern tumour initiation and progression are needed to facilitate the development of innovative SS-based treatments. Elucidating the specific anticancer pathways activated by SS and further clarifying how comprehensive therapies lead to cross-link among the different types of cell death will inspire the clinical translation of SS as cancer treatments. Keywords: apoptosis, autophagy, ferroptosis, pyroptosis 
546 |a EN 
690 |a apoptosis 
690 |a autophagy 
690 |a ferroptosis 
690 |a pyroptosis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Drug Design, Development and Therapy, Vol Volume 18, Pp 3697-3714 (2024) 
787 0 |n https://www.dovepress.com/saikosaponins-targeting-programmed-cell-death-as-anticancer-agents-mec-peer-reviewed-fulltext-article-DDDT 
787 0 |n https://doaj.org/toc/1177-8881 
856 4 1 |u https://doaj.org/article/2dbf8aeb00e341a082b2713a0b53b5eb  |z Connect to this object online.